Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthstream (HSTM) EBITDA (2016 - 2025)

Healthstream (HSTM) has disclosed EBITDA for 16 consecutive years, with $2.4 million as the latest value for Q4 2025.

  • Quarterly EBITDA rose 121.07% to $2.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.2 million through Dec 2025, up 290.03% year-over-year, with the annual reading at $24.1 million for FY2025, 168.57% up from the prior year.
  • EBITDA for Q4 2025 was $2.4 million at Healthstream, down from $7.6 million in the prior quarter.
  • The five-year high for EBITDA was $7.6 million in Q3 2025, with the low at -$11.4 million in Q4 2024.
  • Average EBITDA over 5 years is $2.0 million, with a median of $3.4 million recorded in 2021.
  • The sharpest move saw EBITDA crashed 1225.65% in 2022, then soared 121.07% in 2025.
  • Over 5 years, EBITDA stood at -$460000.0 in 2021, then plummeted by 1225.65% to -$6.1 million in 2022, then decreased by 29.19% to -$7.9 million in 2023, then crashed by 44.85% to -$11.4 million in 2024, then skyrocketed by 121.07% to $2.4 million in 2025.
  • According to Business Quant data, EBITDA over the past three periods came in at $2.4 million, $7.6 million, and $5.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.